Targeted cancer therapy with novel high drug-loading nanocrystals.
暂无分享,去创建一个
F. Liu | Yang Liu | Leaf Huang | C. Conwell | Ji-Young Park | S. R. Bathula | Yong Zhang | Feng Liu
[1] Sampath C Abeylath,et al. Drug delivery approaches to overcome bacterial resistance to β-lactam antibiotics , 2008 .
[2] Robert J. Lee,et al. Targeted drug delivery via folate receptors , 2008 .
[3] A. Nornoo,et al. Cremophor-free intravenous microemulsions for paclitaxel I: formulation, cytotoxicity and hemolysis. , 2008, International journal of pharmaceutics.
[4] J. B. Hall,et al. Characterization of nanoparticles for therapeutics. , 2007, Nanomedicine.
[5] Raj Bawa,et al. Recent advances in basic and clinical nanomedicine. , 2007, The Medical clinics of North America.
[6] T. Stinchcombe,et al. Nanoparticle albumin-bound paclitaxel: a novel Cremphor-EL-free formulation of paclitaxel. , 2007, Nanomedicine.
[7] R. Bawa. Patents and nanomedicine. , 2007, Nanomedicine.
[8] Xiaoling Fang,et al. Difunctional Pluronic copolymer micelles for paclitaxel delivery: synergistic effect of folate-mediated targeting and Pluronic-mediated overcoming multidrug resistance in tumor cell lines. , 2007, International journal of pharmaceutics.
[9] J. Schellens,et al. Novel paclitaxel formulations for oral application: a phase I pharmacokinetic study in patients with solid tumours , 2007, Cancer Chemotherapy and Pharmacology.
[10] G. Kwon,et al. Polymeric micelles for drug delivery. , 2006, Current pharmaceutical design.
[11] V. Torchilin,et al. Polyethylene glycol-phosphatidylethanolamine conjugate (PEG-PE)-based mixed micelles: some properties, loading with paclitaxel, and modulation of P-glycoprotein-mediated efflux. , 2006, International journal of pharmaceutics.
[12] R. Panchagnula,et al. Development and characterization of biodegradable chitosan films for local delivery of paclitaxel , 2004, The AAPS Journal.
[13] D. Kerr,et al. Phase I dose escalation and pharmacokinetic study of pluronic polymer-bound doxorubicin (SP1049C) in patients with advanced cancer , 2004, British Journal of Cancer.
[14] J. Reddy,et al. Preclinical evaluation of (99m)Tc-EC20 for imaging folate receptor-positive tumors. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[15] G. Kwon,et al. The effects of Pluronic block copolymers on the aggregation state of nystatin. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[16] P. Grass,et al. Conditioning Following Powder Micronization: Influence on Particle Growth of Salbutamol Sulfate , 2003, Drug development and industrial pharmacy.
[17] V. Torchilin,et al. PEG-PE/Phosphatidylcholine Mixed Immunomicelles Specifically Deliver Encapsulated Taxol to Tumor Cells of Different Origin and Promote their Efficient Killing , 2003, Journal of drug targeting.
[18] T. Mekhail,et al. Paclitaxel in cancer therapy , 2002, Expert opinion on pharmacotherapy.
[19] D. Aggarwal,et al. Paclitaxel and its formulations. , 2002, International journal of pharmaceutics.
[20] L Yu,et al. Amorphous pharmaceutical solids: preparation, characterization and stabilization. , 2001, Advanced drug delivery reviews.
[21] J. Beijnen,et al. Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[22] B. Dutrillaux,et al. Methionine deprivation and methionine analogs inhibit cell proliferation and growth of human xenografted gliomas. , 1997, Life sciences.
[23] W. Figg,et al. A Preliminary Risk-Benefit Assessment of Paclitaxel , 1995, Drug safety.
[24] P. Low,et al. Endocytosis of folate-protein conjugates: ultrastructural localization in KB cells. , 1993, Journal of cell science.
[25] J. C. Robbins,et al. Modified in vivo behavior of liposomes containing synthetic glycolipids. , 1981, Biochimica et biophysica acta.
[26] M. Sznitowska,et al. Paclitaxel solubility in aqueous dispersions and mixed micellar solutions of lecithin. , 2008, Chemical and pharmaceutical bulletin.
[27] José Juan Escobar-Chávez,et al. Applications of thermo-reversible pluronic F-127 gels in pharmaceutical formulations. , 2006, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.